Stamos Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Sell
15,763
-1,684
-10% -$500K 0.73% 45
2025
Q4
$4.76M Buy
17,447
+6,727
+63% +$1.83M 0.77% 39
2025
Q3
$2.9M Sell
10,720
-3,011
-22% -$819K 0.55% 50
2025
Q2
$3.78M Buy
13,731
+2,542
+23% +$691K 0.68% 49
2025
Q1
$2.97M Sell
11,189
-6,011
-35% -$1.48M 0.78% 35
2024
Q4
$3.99M Buy
17,200
+6,690
+64% +$1.54M 0.94% 32
2024
Q3
$2.32M Sell
10,510
-1,070
-9% -$221K 0.55% 59
2024
Q2
$2.28M Buy
+11,580
New +$2.39M 0.48% 60

Other funds holding CME

Stamos Capital Partners's CME Position: Q1 2026 in Review

Stamos Capital Partners reduced its CME Group (CME) stake by 9.7% in Q1 2026, selling an estimated $500K and leaving 15,763 shares worth $4.66M. The position accounts for 0.73% of the portfolio, ranked #45.

Stamos Capital Partners first reported a position in CME in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.76M in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Stamos Capital Partners held 15,763 shares of CME Group worth $4.66M as of Q1 2026.
  • Stamos Capital Partners sold 1,684 CME Group shares in Q1 2026, an estimated $500K.
  • CME Group made up 0.73% of Stamos Capital Partners's portfolio in Q1 2026, its #45 holding.
  • Stamos Capital Partners first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
  • Stamos Capital Partners's CME Group position peaked at $4.76M in Q4 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.